An Open-Label, 2 Treatment Period,Study To Study The Drug Interaction Between Repeated Doses Of Itraconazole And Single Dose Pharmacokinetics (PK) Of PF-06648671 In Healthy Adults.

• Status: Completed
• Trial end date: 2016-11-01

Summary

This study is to evaluate the effect of multiple doses of itraconazole, the potent cytochrome P450 enzymes (CYP3A) inhibitor, on the pharmacokinetics of PF-06648671 following a single dose administration in healthy subject.

• Phase: Phase 1

Details

• Lead Sponsor: Pfizer
• Treatments: Hydroxyitraconazole; Itraconazole